PSOJ supports MAJ's suggestion for Ivermectin to treat COVID-19

February 26, 2021

The Private Sector Organisation of Jamaica (PSOJ) has come out in support of the Medical Association of Jamaica's (MAJ) recommendation that the drug IVERMECTIN be incorporated into the island's COVID-19 management protocols.

"We call on the Government, and particularly the Ministry of Health and Wellness, to urgently move to import supplies of the drug into the country and to authorise its use at the discretion of qualified physicians, for prophylaxis and early therapy to reduce hospitalisation, severe disease and death," the organisation said in a statement today.

It added: "All interventions that can be employed to save the lives of Jamaicans must be urgently evaluated and implemented."

The PSOJ also welcomed the announcement that 50,000 doses of Astra Zeneca vaccine that will be donated by the Indian High Commission.

However, the PSOJ said it remains extremely concerned about the number of hospital admissions and the increase in the number of deaths due to the COVID-19 pandemic.

“Our hospitals are close to full capacity and the national resources, particularly the human resources, are extremely constrained,” it noted.

Up to Thursday, Jamaica recorded 22,471 COVID-19 cases with 8,608 being active as well as 413 deaths.

The PSOJ once again urged Jamaicans to continue to observe the COVID-19 infection control protocols by wearing masks, frequently washing hands, sanitising and physical distancing when in public spaces.

“We are also recommending that persons get vaccinated when the COVID-19 vaccines become available,” the statement added.

Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us at onlinefeedback@gleanerjm.com or editors@gleanerjm.com.

Other News Stories